NCT07431489
- Conditions
- MEK Inhibitor-Associated Retinopathy, Malignant Melanoma, Melanoma, +11 more
- Locations
-
- Institute of Oncology Ljubljana Ljubljana, Slovenia
Clinical trial condition
Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.
NCT07431489
NCT07428954
NCT03400332
NCT07428941
NCT01659151
NCT02517736
NCT04552223
NCT03820986
NCT01625351
NCT02910557